Guggenheim Capital’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-44,847
| Closed | -$1.83M | – | 1959 |
|
|
2024
Q2 | $1.83M | Buy |
44,847
+19,019
| +74% | +$778K | 0.01% | 842 |
|
|
2024
Q1 | $1.09M | Buy |
25,828
+1,229
| +5% | +$52K | 0.01% | 1152 |
|
|
2023
Q4 | $1.04M | Buy |
24,599
+10,177
| +71% | +$432K | 0.01% | 1141 |
|
|
2023
Q3 | $315K | Buy |
14,422
+1,055
| +8% | +$23K | ﹤0.01% | 1602 |
|
|
2023
Q2 | $425K | Buy |
13,367
+1,443
| +12% | +$45.9K | ﹤0.01% | 1536 |
|
|
2023
Q1 | $291K | Buy |
11,924
+1,430
| +14% | +$34.9K | ﹤0.01% | 1691 |
|
|
2022
Q4 | $331K | Buy |
+10,494
| New | +$331K | ﹤0.01% | 1639 |
|